This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miao, Z.-H. Articles by Pommier, Y. Search for Related Content PubMed PubMed Citation Articles by Miao, Z.-H. Articles by Pommier, Y.

4-Nitroquinoline-1-Oxide Induces the Formation of Cellular Topoisomerase I-DNA Cleavage Complexes

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Yves Pommier, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Building 37, Room 5068, Bethesda, MD 20892-4255. Phone: 301-496-5944; Fax: 301-402-0752; E-mail: pommier{at}nih.gov.

RecQ helicase BLM-deficient cells are characteristically hypersensitive to 4-nitroquinoline-1-oxide (4NQO). We recently reported that isogenic BLM-deficient cells (PNSG13) are more sensitive than BLM-complemented cells (PNSF5) to camptothecin, which specifically traps topoisomerase I cleavage complexes (Top1cc). We now report that PNSG13 are also 3.5-fold more sensitive to 4NQO compared with PNSF5 and that 4NQO induces higher levels of Top1cc and reduced histone -H2AX in PSNG13 than in PNSF5. Similarly, 4NQO induces more Top1cc in primary fibroblasts from a patient with Bloom syndrome than in normal human fibroblasts. 4NQO also induces Top1cc in colon cancer HCT116 and HT29 cells in a time- and concentration-dependent fashion. Of note, distinct from camptothecin, the Top1cc produced by 4NQO accumulate progressively after 4NQO addition and persist following 4NQO removal. The Top1cc induced by 4NQO are detectable by alkaline elution. To examine the functional relevance of the Top1cc induced by 4NQO, we used two stable topoisomerase I small interfering RNA (siRNA) cell lines derived from HCT116 and MCF7 cells. Both topoisomerase I siRNA cell lines are resistant to 4NQO, indicating that Top1cc contribute to the cellular activity of 4NQO. Collectively, these data show that 4NQO is an effective inducer of cellular Top1cc. Because 4NQO does not directly trap Top1cc in biochemical assays, we propose that active metabolites of 4NQO trap Top1cc by forming DNA adducts. Induction of Top1cc and histone -H2AX by 4NQO may contribute to the cellular effects of 4NQO, including its selective activity toward RecQ helicase BLM-deficient cells.(Cancer Res 2006; 66(13): 6540-5)

This article has been cited by other articles:

				A. Derijck, G. van der Heijden, M. Giele, M. Philippens, and P. de Boer DNA double-strand break repair in parental chromatin of mouse zygotes, the first cell cycle as an origin of de novo mutation Hum. Mol. Genet., July 1, 2008; 17(13): 1922 - 1937. [Abstract] [Full Text] [PDF]

				D. J. Burgess, J. Doles, L. Zender, W. Xue, B. Ma, W. R. McCombie, G. J. Hannon, S. W. Lowe, and M. T. Hemann Topoisomerase levels determine chemotherapy response in vitro and in vivo PNAS, July 1, 2008; 105(26): 9053 - 9058. [Abstract] [Full Text] [PDF]

				V. A. Rao, K. Agama, S. Holbeck, and Y. Pommier Batracylin (NSC 320846), a Dual Inhibitor of DNA Topoisomerases I and II Induces Histone {gamma}-H2AX as a Biomarker of DNA Damage Cancer Res., October 15, 2007; 67(20): 9971 - 9979. [Abstract] [Full Text] [PDF]

				Z.-H. Miao, A. Player, U. Shankavaram, Y.-H. Wang, D. B. Zimonjic, P. L. Lorenzi, Z.-Y. Liao, H. Liu, T. Shimura, H.-L. Zhang, et al. Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses Cancer Res., September 15, 2007; 67(18): 8752 - 8761. [Abstract] [Full Text] [PDF]

				O. Sordet, A. Goldman, and Y. Pommier Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes Mol. Cancer Ther., December 1, 2006; 5(12): 3139 - 3144. [Abstract] [Full Text] [PDF]